Skip to main content
. 2012 Dec 26;7(12):e51728. doi: 10.1371/journal.pone.0051728

Table 1. Results comparing hospital onset with community onset cases.

Hospital associated (%)(N = 53) Community associated (%) (N = 22) Total (%)(N = 75) p- values
Age (yrs) <2 years 16 (30.2) 20 (90) 36 (48) 0.0001
2–5 years 26 (49) 1 (4.5) 27 (36)
>6 years 11 (20.7) 1 (4.5) 12 (16)
Gender Male 25 (47.2%) 12 (54.5%) 37 (49.4%)
Year 2005 14 13 27
2006 11 4 15
2007 15 5 20
2008 9 0 9
2009 4 0 4
Co-morbidities * Cardiovascular 3 (5.7) 0 3 (4)
Neuromuscular 3 (5.7) 1 (4.5) 4 (5.3)
Gastrointestinal 3 (5.6) 5 (22.7) 8 (10.7) <0.0001
Haematology + immunosuppression 11 (20.7) 1 (4.5) 12 (16) 0.0001
Malignancy (solid organ) 20 (37.7) 0 20 (26.7) 0.0001
Renal+Metabolic 3 (5.6) 0 3 (4)
Cows milk allergy 1 (1.8) 6 (11.3) 7 (9.3) <0.0001
Respiratory 1 (1.8) 1 (4.5) 2 (2.7)
Others 7 (13) 3 (13.6) 10 (13.3)
Antibiotic history Penicillins (Amoxicillin & Co-amoxiclav) 5 (9.4) 5 (22) 10 (13.4)
Cephalosporins 27 (50.9) 3 (13.6) 30 (40)
Quinolones (Ciprofloxacin) 19 (35.8) 0 19 (25)
Others 5 (9.4) 2 (9) 7 (9.3)
No antibiotics 7 (13.2) 13 (59) 20 (26.7)
Co-infections Bacterial 0 0 0
Viral 6 (11.3) 3 (13.6) 9 (12)
Other risk factors Intensive Care stay 12 (22.6) 0 12 (16)
Surgery** 14 (26.4) 4 (18) 18 (24)
Severity score *** Mild 7 (13.2) 2 (9) 9 (12)
Moderate 6 (11.3) 2 (9) 8 (10.7)
Severe 39 (73.6) 18 (81.8) 57 (76)
Life threatening 1 (1.9) 0 1 (1.4)
Treatment Not required 27 (51) 13 (59) 40 (53.4)
Metronidazole 22 (41.5) 8 (36.4) 30 (40)
Escalation of treatment to Vancomycin 3 (5.7) 0 3 (4)
Probiotics 1 (1.9) 1 (4.5) 2 (2.7)
Outcome Alive at 3 months 45 (81) 19 (81.8) 64 (81.4)
ICU requirement 2 (2.8) 0 2 (2.7)
Colectomy 1 (1.8) 0 1 (1.3)
Crude mortality 2 (3.8) 2 (9) 4 (5.4)
Missing notes 2 1 3
Transferred 3 1 4 (5.4)
*

Note some patients had more than one risk factor.

**

Of the 18 surgeries 9 were gastrointestinal surgeries (Resection of abdominal mass, appendicectomy).

***

Severity scoring criteria as recommended by Department of Health and Health Protection Agency.